[Immunosuppressive therapy in renal disease (author's transl)].
Since immunological events were found to be pathogenetically involved in various forms of glomerulonephritis, corticosteroids and immunosuppressive drugs were introduced in the treatment of nephritis. However, as opposed to the findings in the paediatric nephrotic syndrome, controlled and multicentric trials with immunosuppressive therapy revealed disappointing results in the management of renal disease in adults. Significantly better results under immunosuppressive therapy, were seen only in the nephrotic syndrome based on the so-called "no changes" or "minimal changes" nephritis. In chronic membranous and proliferative glomerulonephritis the clinical course in the treated group was not statistically different from that of the untreated group. In some disorders of connective tissues, such as systemic lupus erythematosus, polyarteritis nodosa and Wegener's granulomatosis, corticosteroids and immunosuppressive agents seem to exert a favourable effect on the course of renal disease. Encouraging results concerning the combined use of immunosuppressive drugs, anticoagulants and platelet aggregation inhibitors in mesangiocapillary (membrano-proliferative) glomerulonephritis and rapidly progressive nephritis have also been presented. Several factors such as incomplete immunosuppression, druginduced antigen tolerance and increased immune complex formation as a consequence of inhibited antibody production may contribute to the fact that many patients with different forms of nephritis do not benefit from long-term immunosuppressive therapy.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002648:Child; D003165:Complement System Proteins; D004697:Endocarditis, Bacterial / Q000150:complications; D005921:Glomerulonephritis / Q000628:therapy; D014890:Granulomatosis with Polyangiitis / Q000150:complications; D006801:Humans; D007165:Immunosuppression Therapy; D007674:Kidney Diseases / Q000628:therapy*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008288:Malaria / Q000150:complications; D009393:Nephritis / Q000209:etiology; D009404:Nephrotic Syndrome / Q000628:therapy; D010974:Platelet Aggregation; D010488:Polyarteritis Nodosa / Q000150:complications
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D003165:Complement System Proteins
Immunsuppressive Therapie der Nierenerkrankungen